Weight loss drug may reduce heart failure risk
This article was originally published in English New results from a clinical trial evaluating the drug show positive results in reducing the risk of heart failure. ADVERTISING The slimming drug Tirzepatide reduced the risk of hospitalization by 38% or death in obese adults with heart failure, compared with a placebo, according to Eli Lilly. The … Read more